Swami has really turbocharged this company after the lost couple of years with Paul B promising a lot on Hernia and Breast and delivering nothing.
Outstanding results in existing US and ANZ markets, focused global expansion by reinventing UK Europe , entries in Hong Kong and Canada and developing an entry strategy for the big underserved markets with an entry into India.
He never gives away to much but it’s obvious they are progressing an exciting program of new products and Japan and China are definitely on his radar.
Amazing what a difference a true global executive with blue chip company experience can make with a passion for great patients outcomes as well as financial results.
Swami has really turbocharged this company after the lost couple...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
-0.040(1.62%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $2.48 | $2.51 | $2.43 | $1.692M | 690.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 19941 | $2.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.45 | 4032 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |